(84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
Designated Extension States: |
|
AL LT LV MK RO SI |
(30) |
Priority: |
14.02.2000 US 504653
|
(71) |
Applicants: |
|
- Cytoclonal Pharmaceutics, Inc.
Dallas, Tx 75235 (US)
- University of Texas at Dallas,Department of Molecular and Cell Biology
Richardson, Tx 75083-0688 (US)
- Laboratory of Experimental Carcinogenesis,National Cancer Institute/NIH
Bethesda, MD 20892-4285 (US)
|
|
(72) |
Inventors: |
|
- Cytoclonal Pharmaceutics, Inc.
Dallas, Tx 75235 (US)
- University of Texas at Dallas,Department of Molecular and Cell Biology
Richardson, Tx 75083-0688 (US)
- Laboratory of Experimental Carcinogenesis,National Cancer Institute/NIH
Bethesda, MD 20892-4285 (US)
|
(74) |
Representative: Stark, Amanda Jane et al |
|
Abel & Imray,20 Red Lion Street London WC1R 4PQ London WC1R 4PQ (GB) |
|